Charles Schwab Investment Management »

Verve Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2M 370k 13.94
2023-09-30 $4.8M 363k 13.26
2023-06-30 $6.3M 335k 18.75
2023-03-31 $4.6M 322k 14.42
2022-12-31 $6.2M 321k 19.35
2022-09-30 $11M 307k 34.35
2022-06-30 $2.2M 145k 15.28
2022-03-31 $3.5M 154k 22.83
2021-12-31 $3.9M 105k 36.88
2021-09-30 $4.8M 103k 47.01